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ABSTRACT
Engineered functional skeletal muscle would be beneficial in reconstructive surgery. Our previous work
successfully generated 3-dimensional vascularized skeletal muscle in vivo. Because neural signals direct
muscle maturation, we hypothesized that neurotization of these constructs would increase their contractile
force. Additionally, should neuromuscular junctions (NMJs) develop, indirect stimulation (via the nerve)
would be possible, allowing for directed control. Rat myoblasts were cultured, suspended in fibrin gel, and
implanted within silicone chambers around the femoral vessels and transected femoral nerve of syngeneic
rats for 4 weeks. Neurotized constructs generated contractile forces 5 times as high as the non-neurotized
controls. Indirect stimulation via the nerve elicited contractions of neurotized constructs. Curare admin-
istration ceased contraction in these constructs, providing physiologic evidence of NMJ formation. His-
tology demonstrated intact muscle fibers, and immunostaining positively identified NMJs. These results
indicate that neurotization of engineered skeletal muscle significantly increases force generation and
causes NMJs to develop, allowing indirect muscle stimulation.
INTRODUCTION
T ISSUE ENGINEERING IS A PROMISING APPROACH to the ever-increasing need for treatment of tissue loss and end-
stage organ failure. In 1993, more than $400 billion was
spent, and more than 8 million procedures were performed
to treat patients suffering from organ failure or tissue loss.1
A reliable and renewable source of skeletal muscle would
be of great benefit to the patient who has lost muscle tissue
or muscular function.
Previously, we have used a model of spontaneous angio-
genesis that proved to be an excellent platform on which to
generate in vivo 3-dimensional (3-D), vascularized, func-
tional cardiac and skeletal muscle constructs.2,3 For these
experiments, we adapted a method that creates a potential
space around a vascular pedicle.4 The vascular pedicle con-
sists of an artery, a vein, and the adherent connective tissue.
Over time, the void within the chamber spontaneously fills
with neoangiogenic tissue, providing a well-vascularized
platform to support the survival and growth of 3-D tissues.
Vascularization of our previous engineered skeletal mus-
cle constructs permitted development of larger, stronger
constructs than was possible in vitro.5 Despite this, the
specific forces generated by native skeletal muscle were 4
orders of magnitude greater than the engineered constructs
(35.4 N/m2 vs. 239.7 kN/m2 for mouse extensor digitorum
longus muscle).3 Because the expression of adult phenotype
in muscle is directly related to the innervation and activa-
tion pattern of the muscle,6,7 we hypothesized that neuro-
tization of the tissue-engineered skeletal-muscle constructs
would result in the formation of neuromuscular junctions
(NMJs), thereby improving force production and provid-
ing the means for indirect myocyte stimulation. Also, by
introducing neural components to these axially vascularized
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constructs formed in vivo, we may provide them with their
own neurovascular pedicle, thus facilitating their microsur-
gical transfer for future functional reconstruction purposes.
To produce a skeletal muscle construct with better func-
tional potential, we sought to neurotize the developing skel-
etal muscle constructs in vivo. Previous studies of in vitro
neurotized, cultured myocytes have described histological
and chemical-biological interactions at the NMJ that lead to
faster phenotypic maturity.8–10 Additionally, nerve-induced




The University Committee for the Use and Care of An-
imals granted institutional approval for animal use in accor-
dance with the ‘‘Guide for the Care and Use of Laboratory
Animals’’12. Rats were housed individually in a restricted-
access, pathogen-free facility. They had access to food and
water ad libitum and were exposed to a 12-h light–dark
cycle. All materials were purchased from Sigma (St. Louis,
MO) unless otherwise specified.
Isolation of skeletal myocytes
Skeletal satellite cells were isolated from adult Fisher-
344 rat soleus muscle, a large skeletal muscle found in the
lower leg, using an established method.13 The excised soleus
muscles were placed in phosphate buffered saline (PBS)
and then rinsed 3 to 4 times in sterile PBS to remove debris.
The muscle was then cut into fine pieces and dissociated in
a dissociation solution made of collagenase type II (0.1 %)
and dispase (0.05%) diluted in serum-free Dulbecco’s mod-
ified Eagle medium (DMEM), for 3 h in a 378C shaking
water bath. After digestion, the solution was filtered through
a 100-mm filter and centrifuged at 2,500 revolutions per min
for 6min to pellet the cells. The supernatant was removed,
and the cell pellet was resuspended in fresh growth medium
(10% heat-inactivated fetal bovine serum and 5 ng/mL fi-
broblast growth factor-2 in F12K nutrient mixture con-
taining 100U  100mg1 mL penicillin streptomycin1 and
2.5 mg/mL Fungizone). The cells were plated overnight, and
the nonadherent cells were transferred to new plates to form
additional cultures and increase our yield of skeletal cells.
After the cells grew to 70% confluence, they were trypsi-
nized with 1mL of 0.025% trypsin per plate.
Preparation of the chambers for implantation
Silicone tubing (3.2mm inner diameter, 4.8mm outer
diameter, wall thickness 0.8mm; Cole Parmer Instrument
Company, Vernon Hills, IL) was cut to lengths of 10mm,
making an internal volume of 80 mL. A longitudinal slit was
made down the length of each tube to allow it to be opened
length-wise for placement around the intact femoral vessels.
The previously isolated skeletal myocytes were suspended
in a fibrinogen solution (50 mL of cells/culture medium and
20 mL of 20-mg/mL fibrinogen Sigma) to obtain 6 million
cells per chamber. The cell and fibrinogen suspension was
pipetted into vertically oriented silicone tubes containing
10 mL of 200-U/mL thrombin. Four chambers were pre-
pared for each study group.
Implantation of chambers
Non-neurotized control procedure. Cell-seeded chambers
were implanted into 4 adult F344 rats weighing approxi-
mately 250 to 300 g each. The animals were anesthetized
using an intraperitoneal injection of 0.5mL of sodium pen-
tobarbital (Abbott Laboratories, Chicago, IL). Their groins
were shaved, sterilely prepared, and draped. The right
femoral vessels were exposed through a longitudinal inci-
sion made at the groin. With the aid of an operative mi-
croscope, the femoral artery and vein were separated from
their surrounding tissues and the accompanying femoral
nerve. Several small vascular branches to the thigh mus-
culature were cauterized to isolate the femoral vessels over
their lengths from the inguinal ligament to the branch point
of the epigastric vessels. The previously prepared skeletal
myocyte- and fibrin gel–filled tubes were placed around the
femoral vessels by passing the intact vascular pedicle through
the slit in the side of the silicone tubes. The wounds were
closed in 2 layers.
Neurotized experimental procedure. On the left side of
each of the above animals, the femoral vessels were exposed
as above, and the nerve was dissected away from the vas-
cular structures (Fig. 1A). The femoral nerve was then tran-
sected at an oblique angle so as to maximally expose the
cross-sectional area of the proximal transected stump to the
myoblasts in the chamber. The epineurium of the femoral
nerve’s proximal stump was then sutured to the connective
tissue surrounding the femoral artery to position the severed
nerve end into the middle of the developing construct (Fig.
1B, C). A myocyte- and fibrin gel–filled chamber was again
placed around the intact femoral vessel and the proximal
stump of the femoral nerve (Fig. 1B, D). The wound was
closed in 2 layers, and the animal was allowed to recover.
Constructs were implanted in this manner as the experimen-
tal procedure.
Retrieval of chambers
The constructs were allowed to mature in vivo for 4 weeks
in this study, compared with the 3-week in vivo period of
our earlier studies.3 The rationale for this was to increase
the time needed for NMJ formation. After 4 weeks, the rats
were re-anesthetized, and the chambers were isolated. The
silicone tubes were opened along their longitudinal slit, and
the patency of the vascular pedicles was confirmed using
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visual observation of blood flow through the vessels. The
femoral artery and femoral vein were ligated and divided
proximally and distally to the newly formed skeletal muscle
constructs for the non-neurotized control side and the neuro-
tized experimental side (Fig. 1E). The proximal stump of
the femoral nerve was identified on the experimental side
and was dissected free and divided proximally, leaving a
proximal length attached to the construct (Fig. 1F). Once
the skeletal muscle construct was freed, the severed nerve
end was submerged in a solution of 50% polyethylene
FIG. 1. In vivo vascularized, neurotized skeletal muscle construct development. (A) Drawing of rat in supine position with left groin
dissected, demonstrating the inguinal ligament, femoral artery, femoral vein, and femoral nerve. (B) Drawing of a rat’s left groin with
femoral nerve transected and sutured to the adventitia of the femoral artery. The silicone chamber filled with myoblast and fibrin gel has
been placed around the vascular pedicle and proximal stump of the femoral nerve. (C) Dissected rat groin with the femoral artery (FA)
and femoral vein (FV). The proximal stump of the femoral nerve (arrow) has been sutured to the adventitia of the femoral artery.
(D) Photo taken at the time of implantation. The silicone chamber, filled with myoblast and fibrin gel, has been placed around the intact
femoral vessels and the proximal stump of femoral nerve (proximal vessels at left of picture, distal vessels at right). (E) Photo taken at
the time of explantation. The silicone chamber has been removed, the proximal stump of femoral nerve (arrow) is well incorporated into
the skeletal muscle construct, and proximal vessels (left) and distal vessels (right) are ligated. Note the newly formed cylinder of
vascularized muscle tissue. (F) Photo of the neurotized skeletal muscle construct after harvest. Note the nerve entering the muscle
construct (arrow). Color images available online at www.liebertpub.com/ten.
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glycol (molecular weight 3000) in DMEM for 2min to
repair nerve membrane damage and prevent loss of nerve
impulse conduction.14 The constructs were then placed into
a 35-mm tissue culture plate coated with polydimethylsil-
oxane substrate (Dow Chemical Corporation, Midland, MI).
DMEM with an antibiotic–antimycotic solution (Invitrogen
Corporation, Auckland, New Zealand) was added to each
plate. The contractility characteristics of the tissues were
then determined, as described below.
Functional assessment
Field stimulation. The functional capabilities of the skele-
tal muscle constructs were measured according to active
contractile force production ex vivo. Force testing was not
performed in situ because the skeletal muscle construct was
not fixed to any stable structure. After explanting the con-
struct, one endwas fixed to a stationary position and the other
end of the construct was fixed to a force transducer. The
method for evaluating the active contractile force of en-
gineered muscle has been described in detail in previous
work.13 Briefly, following explantation, each construct was
placed in a 35-mm culture dish with DMEM culture medium,
maintained at 378C (Fig. 2). One end of the construct was
fixed by a pin attached to the bottom of the dish and the
other end of the construct was connected to a custom-built
force transducer. A custom LabView software program
(National Instruments, Austin, TX) running on a personal
computer controlled the data input–output board. The Lab-
View program and data input–output board generated output
voltage signals that were amplified and delivered to the
construct as direct field stimulation via 2 platinum electrode
wires laying parallel to the constructs, one electrode on ei-
ther side of the construct. Electrical stimulation was applied
to the construct to generate contractile forces. Pulses having a
15 volt amplitude and a 1.2ms width were used to determine
peak twitch force. These parameters were chosen based on
previous studies in which stimulation voltage was varied
between 5 and 30 volts, to arrive at optimal stimulation pa-
rameters. In these past experiments, it was found that 15 volts
was great enough to excite the tissue-engineered skeletal
muscles tomaximally contract, but not causing overt damage.
Additionally, by using a narrower stimulation protocol, we
decreased the amount of time that the constructs were stim-
ulated in an ex vivo environment. Peak tetanic forces (forces
generated while stimulating a constant, sustained contrac-
tion) were determined with a 1 second train of pulses (15 volt
at 1.2ms width) for which the pulse frequency was varied
between 5 and 150Hz, to determine the maximal tetanic
force generation per construct.
Indirect stimulation
Following direct field stimulation, each neurotized skel-
etal muscle construct was also stimulated indirectly, via the
nerve. Needle electrodes were positioned so that the elec-
trodes were touching the nerve, and an electrical stimulus
of 1 to 5 volts was given for 1.2ms (Fig. 3A, C). Twitch
contractile forces were measured rather than tetanic forces
secondary to concern of ‘‘burning out’’ the nerve with tetanic
stimulation. To ensure that any resultant force from the in-
tended indirect stimulation was not the result of direct field
stimulation, the electrodes were then disconnected from the
nerve and placed at a point equidistant from the muscle
construct but not touching the nerve (Fig. 3B, D), and stim-
ulation and force recording were again performed. Lastly,
to ensure that any contractile forces caused by the indirect
stimulation were due to intact neural communication with
FIG. 2. (A). Drawing of a skeletal muscle construct after harvest
from the rat in preparation for direct (field) stimulation. The tissue-
engineered construct is placed in a tissue culture dish with culture
medium. The muscle construct is pinned to the dish on one end
(right side), and the other end of the muscle is attached to a force
transducer arm. Field stimulation electrodes are placed along both
sides, parallel to the muscle. Upon electrical stimulation, the mus-
cle contracts in a linear fashion, and the force transducer measures
the force produced. (B) Direct (field) stimulation of the skeletal
muscle construct. The muscle is pinned to the dish at the right.
Note the force transducer, field electrodes, and nerve. Color images
available online at www.liebertpub.com/ten.
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the muscle via NMJs and not solely due to the nerve acting as
physical electrical conduit, the electrodes were again placed
touching the nerve. Before repeat indirect stimulation, curare
(tubocurarine chloride hydrate, Sigma), a potent NMJ in-
hibitor, was dissolved in a buffered physiological salt solu-
tion (137mM sodium chloride, 24mM sodium bicarbonate,
11mM glucose, 5mM potassium chloride, 2mM calcium
chloride, 1mM magnesium sulfate, 1mM sodium dihydro-
gen phosphate, and 0.024mM tubocurarine chloride).15 The
curare solution was added to the muscle bath solution,
and the electrical stimulation and contraction recording were
then repeated.
Histological assessment
After functional assessment, the skeletal muscle con-
structs were embedded in tissue freezing medium (Triangle
Biomedical Sciences, Durham, NC), frozen in liquid nitro-
gen, and stored at –808C. The frozen constructs were sec-
tioned in a –308C cryotome and placed on glass slides. The
sections were then fixed in cold acetone. Sections of neuro-
tized and non-neurotized muscle constructs were routinely
stained with hematoxylin and eosin and evaluated for the
presence of NMJs using an immunostaining technique us-
ing alpha-bungarotoxin, a substance known to bind to the
neuromuscular nicotinic acetylcholine receptors of NMJs.
For alpha-bungarotoxin staining, the previously sectioned,
frozen slides were allowed to thaw for 30min at room
temperature then fixed in 100% methanol at –208C for
10min. PBS was pipetted onto the slide for 3min and
removed. The fluorescein isothiocyanate–labeled alpha-
bungarotoxin (Sigma-Aldrich, St. Louis, MO) was diluted,
15 mL in 1.5mL of PBS, and added to the slides. After
5min, the alpha-bungarotoxin–PBS was removed, and the
slides were rinsed with PBS 5 times. Then 40,6-diamidino-
2-phenylindole (Sigma-Aldrich) counterstain was added to
each slide, a cover slip was placed over the sectioned tissue,
and the tissues were visualized using an immunofluorescent
microscope. Digital images were taken with an Olympus
DP70 digital camera and associated software through an
Olympus BX 51 microscope (Hamburg, Germany).
Statistical analysis
The mean stimulation contraction force value, standard
errors, and one-way analysis of variance were calculated
for each implantation site. A p< 0.05 was considered sig-
nificant.
RESULTS
After 4 weeks of in vivo implantation, all 8 chambers
were explanted (Fig. 1E, F). It was found that the chambers
were filled with viable tissue occupying their entire vol-
ume. The femoral vessels had incorporated into the newly
formed tissue and remained intact and patent. At the neu-
rotized construct sites, the proximal stumps of the femoral
nerves were incorporated into the constructs.
Functional results
Direct muscle field stimulation generated visible con-
tractions in the construct and measurable force in all 8
constructs tested, including those with or without nerve
stump implants. Force values for the control skeletal muscle
constructs demonstrated an average peak tetanic force of
124 31 mN, which is consistent with our earlier pub-
lished data on non-neurotized, vascularized skeletal muscle
constructs.3 The average tetanic forces generated by the
FIG. 3. Indirect (via the nerve) skeletal muscle construct stimu-
lation. (A) Drawing of a skeletal muscle construct in growth
medium with electrodes placed directly into the nerve. The muscle
construct is still pinned to the dish at the right and connected to
the force transducer at the left. (B) Drawing of the skeletal muscle
construct with the electrodes removed from the nerve and placed
at an equidistant point from the muscle construct as in the pre-
vious indirect stimulation. (C) Neurotized skeletal muscle con-
struct pinned to a culture dish and attached to the force transducer.
Field stimulation wires are removed and replaced with electrodes
that are inserted directly into the nerve (arrow). (D) Electrodes
placed at an equidistant location from the muscle construct but not
touching the nerve to exclude the possibility that direct field
stimulation, rather than indirect stimulation via the nerve, resulted
in muscle contraction. (E) Force tracing after indirect stimulation
with electrode touching nerve. (F) Force tracing after electrical
stimulation with electrode not touching nerve but at equidistant
point from muscle construct. Color images available online at
www.liebertpub.com/ten.
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neurotized skeletal muscle constructs in response to direct
field stimulation averaged 649 228 mN ( p< 0.05, Fig. 4),
more than 5 times as great as at the non-neurotized con-
trol sites.
After the direct field stimulation tests, indirect stimula-
tion of a neurotized construct was performed by placing
needle electrodes in contact with the nerve (Fig. 3C). With
indirect electrical stimulation, the experimental, neurotized
skeletal muscle construct generated measurable linear force
contractions (Fig. 3E), producing an average of 20.4 mN of
twitch force (Fig. 4). Immediately after indirect stimula-
tion, the electrodes were removed from the nerve and placed
in the bath at a point equidistant from the muscle construct
to determine whether the force produced was due to field
stimulation rather than indirect stimulation down the nerve.
With electrical stimulation in this configuration, no force
was elicited (Fig. 3F). Next, the electrodes were replaced
into the nerve, and stimulated contraction was again con-
firmed. Lastly, without disturbing the construct, nerve, or
electrodes, curare, a potent neuromuscular junction inhib-
itor was added to the bath. Repeat indirect stimulation
elicited no force from any of the neurotized constructs.
Histological results
Hematoxylin and eosin staining demonstrated results
similar to those previously reported, including the presence
of surviving skeletal muscle cells interspersed with colla-
gen deposition and robust angiogenesis sprouting from the
femoral vessels. Examination of sections from neurotized
constructs immunostained with the alpha-bungarotoxin
technique identified rare NMJ presence (Fig. 5). A com-
prehensive analysis of the tissues in an attempt to quantify
NMJ’s was not performed. This study surveyed random sec-
tions to identify the presence of NMJ’s. No NMJs were
identified in the non-neurotized controls.
DISCUSSION
Several tissue-engineering techniques have been used in
the effort to produce skeletal muscle. Researchers have
created muscle tissue using in vitro ‘‘self-assembly’’ tech-
niques5,13,16–18 and in vivo implantation techniques.3,4,19
Additionally, skeletal muscle constructs have been pro-
duced by seeding myoblasts onto scaffolds to achieve 3-D
tissues in vitro20–24 and in vivo.25–28 These scaffolds have
been composed of a variety of materials, including poly-L-
lactic acid/polylactic-glycolic acid sponges,26 acellularized
skeletal muscle,20,27 polyglycolic acid meshes,25,28 and sus-
pensions of alginate or hyaluronic acid hydrogels.25 Sig-
nificant research has also been undertaken to understand the
properties required to optimize the scaffolds, such as mate-
rial chemistry and roughness, porosity, wettability, and ar-
chitecture and how these elements best interact with tissue
properties such as cell-adhesion ability.29–31
Diffusion characteristics of oxygen, nutrients, and waste
metabolites of tissues are ultimately what determine the size
of a construct that can be viably sustained. In the attempts
to generate engineered tissue of any size much greater than
FIG. 4. Average peak force. There was a statistical difference
between the average tetanic force of non-neurotized skeletal mus-
cle controls (124 31 mN) and the average tetanic force of neu-
rotized skeletal muscle constructs (649 228mN) via direct (field)
stimulation ( p< 0.05). Average twitch force of neurotized skel-
etal muscle constructs via indirect stimulation by the nerve was
20.4 mN. The direct forces were obtained during tetany, whereas
the indirect force via the nerve was obtained during twitch stim-
ulation.
FIG. 5. Example of neuromuscular junction formation (arrow)
in a neurotized skeletal muscle construct stained using alpha-
bungarotoxin (100). Color images available online at www
.liebertpub.com/ten.
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200 mm in thickness,32 substantial efforts have been de-
voted in the field of tissue engineering to the vasculariza-
tion of these tissue constructs in vitro26 and in vivo.4,33,34
In vivo vascularization can be augmented by creating tis-
sue that generate angiogenic factors such as vascular
endothelial growth factor, platelet-derived growth factor,
endothelium-derived growth factor, recombinant human
growth hormone, and transforming growth factor-beta us-
ing genetically engineered cells that produce the protein of
interest.35–38 Conversely, vascularization can be induced
via a spontaneous model of angiogenesis.3,4,19,33,34
Our initial attempts at tissue engineering a vascularized
skeletal muscle construct in vivo stemmed from an adapta-
tion of a method of inducing spontaneous angiogenesis from
an arteriovenous vascular pedicle, which, when contained
within a ‘‘chamber,’’ could provide a well-vascularized
platform to support the survival and growth of 3-D tissues.4
We demonstrated the development of axially vascularized
skeletal muscle constructs in vivo in the rat, which exhib-
ited histological and contractile properties similar to those
of native muscle. The observation of numerous myotubes
present within the constructs that stained positively for the
muscle-specific intermediate-filament protein desmin pro-
vided evidence of differentiation of implanted myocytes.
Also, a striated banding pattern similar to that in skeletal
musclewas identified. Physiological properties, namely force
measurements, of these constructs also resembled those of
developing muscles.3 However, the ultimate force produced
was much lower than that of native skeletal muscle (35.4
62.2N/m2 vs 239.7 19.1 kN/m2) for mouse extensor digi-
torum longus muscle.20
We hypothesized that providing neural input to devel-
oping tissue-engineered skeletal muscle constructs would
improve their contractile forces and allow for their indi-
rect stimulation. The neural influence on the develop-
ment of skeletal muscle fibers, on which the hypothesis
of this article is based, is well documented. The relation-
ship between muscle types and motor nerves was estab-
lished in early studies.39 Skeletal muscle properties and the
effects of innervation have been studied using many meth-
ods, including denervation,40,41 and it has been shown that,
with denervation, fast and slow muscle will start to trans-
form into a phenotypically slow muscle. Classic cross-re-
innervation studies have shown that, when the fast flexor
digitorum longus muscle was cross-reinnervated with a
slow tibial nerve, twitch contraction times slowed 50%,
had low adenosine triphosphatase activity, and reacted
with slow myosin antibodies only. In contrast, when the
soleus muscle was cross-reinnervated with a fast flexor
digitorum longus nerve, the contraction time almost dou-
bled, but there were no changes in adenosine triphospha-
tase activity, and there was mixed reactivity to fast and
slow antibodies.42 In similar studies, when the slow-twitch
semimembranosus proprius muscle of the rabbit was cross-
reinnervated with a fast nerve, almost all fibers switched to
a fast phenotype.43
Our findings support our hypothesis that neurotization of
skeletal muscle would increase force-generating capabili-
ties. Specifically, we found that neurotization of develop-
ing skeletal muscle constructs in vivo resulted in a 5-fold
increase in average peak tetanic force over that of non-
neurotized constructs (649 vs 124mN, p< 0.05). In addi-
tion, stimulation of the muscle construct indirectly via the
nerve was successful, eliciting characteristic force tracing,
albeit at a lower twitch force. Upon the addition of curare,
indirect stimulation of the muscle construct ceased produc-
ing contractions. Taken together, these observations pro-
vide physiologic evidence that NMJs developed within the
neurotized constructs. The histologic demonstration ofNMJs
on immunostaining further bolster this conclusion.
There are several possible explanations for the low force-
generating capability of the construct via indirect versus
direct stimulation. One possibility is that only a few axons in
the short experimental time of 4 weeks physically make con-
tact with the muscle. Another possibility is that the muscle
cells that have NMJs do not have well-established intracel-
lular junctions with other myocytes and therefore that few
myocytes receive excitation via indirect stimulation.
A limitation of this study was the ex vivo functional as-
sessment of the skeletal muscle constructs. It would be pos-
sible to stimulate the nerve in vivo, and typically this is the
preferred method to stimulate muscle. However, our con-
structs do not have an origin or insertion point and therefore
are not attached to any fixed structure. By explanting the
construct, we were able to fix one end to a stationary sur-
face and the other end to the force transducer and obtain
reliable force measurements. By explanting the constructs
and performing the force testing ex vivo, we may obtain
suboptimal performance secondary to adenosine triphos-
phate depletion, electrolyte imbalances, and other things,
because of detachment from their intrinsic blood supply.
However, the muscle tissue in the neurotized constructs and
the non-neurotized controls should have been affected sim-
ilarly. Because the experiment was designed only to test the
difference between the neurotized and non-neurotized con-
structs, we felt that the ex vivo testing was an acceptable
method for this initial study.
In this work, we have succeeded in generating in vivo
neurotized, vascularized skeletalmuscle constructs. Through
vascularization, we have been able to create larger skeletal
muscle constructs, and now, with neurotization, we have
been able to increase their contractile forces substantially.
Additionally, with neurotization, we were able to increase
the muscle constructs’ function by being able to direct stim-
ulation and contraction. With the generation of this vascu-
larized, neurotized muscle construct, we are one step closer
to engineering a transplantable tissue flap that can be trans-
ferred microvascularly via an axial blood supply and have
the ability to achieve directedmuscular contractions via nerve
connections.
Future studies will focus on differential neurotization of
tissue-engineered skeletal muscle and how this may affect
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phenotypic maturation and differentiation. Molecular analy-
sis of the skeletal muscle after maturation will be performed
to evaluate myosin heavy chain isoform differences between
these groups. Future experiments, using immunofluorescent-
labeled cultured skeletal myocytes, will also assist in the
analysis of the distribution and quantification of the engi-
neered skeletal muscle tissue and its relationship to NMJs.
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